Clinical deterioration after sildenafil cessation in patients with pulmonary hypertension
Anne M Keogh, Andrew Jabbour, Christopher S Hayward, Peter S MacdonaldHeart Lung Transplant Unit, St Vincent’s Hospital, Sydney, New South Wales, AustraliaAbstract: Sildenafil is a selective inhibitor of phosphodiesterase type 5 (PDE-5). Its chronic administration has been shown to improve...
Main Authors: | Anne M Keogh, Andrew Jabbour, Christopher S Hayward, Peter S Macdonald |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2008-10-01
|
Series: | Vascular Health and Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/clinical-deterioration-after-sildenafil-cessation-in-patients-with-pul-peer-reviewed-article-VHRM |
Similar Items
-
Sildenafil in Infants and Children
by: Larisa Simonca, et al.
Published: (2017-07-01) -
The first Russian experience of sildenafil application in patients with idiopathic pulmonary hypertension
by: Z Kh Dadacheva, et al.
Published: (2015-09-01) -
Pharmacological test with sildenafil at pulmonary hypertension assessing in children with congenital heart diseases
by: O. S. Yanulevich, et al.
Published: (2010-10-01) -
One-year follow-up of the effects of sildenafil on pulmonary arterial hypertension and veno-occlusive disease
by: A.C. Barreto, et al.
Published: (2005-02-01) -
Sildenafil in the treatment of pulmonary hypertension
by: O. S. Groznova, et al.
Published: (2016-03-01)